Showing results (3211-3220 of 3,354) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|January 28, 2023
Cost Effectiveness of Implementing a Universal Birth Hepatitis B Vaccination Program in OntarioJohn J Kim, Wasem Alsabbagh, William W L WongPharmacoeconomics|February 25, 2023
How to Predict Drug Expenditure: A Markov Model Approach with Risk ClassesValeska Hofbauer-Milan, Stefan Fetzer, Christian HagistPharmacoeconomics|February 16, 2026
From Paper to Platform: Updating the Dutch Costing Manual and Launching a Web ApplicationLeona Hakkaart-van Roijen, Stijn B Peeters, Vivian Reckers-Droog, et al.Pharmacoeconomics|February 21, 2025
Innovative Payment Models for Sickle-Cell Disease Gene Therapies in Medicaid: Leveraging Real-World Data and Insights from CMMI's Gene Therapy Access ModelAntal Zemplenyi, Jim Leonard, Garth C Wright, et al.Pharmacoeconomics|November 15, 2024
Cost Effectiveness of Tremelimumab Plus Durvalumab for Unresectable Hepatocellular Carcinoma in the USAXiaomo Xiong, Jeff Jianfei GuoPharmacoeconomics|November 11, 2024
Value-Based Healthcare in Practice: IDEATE, a Collaboration to Design and Test an Outcomes-Based Agreement for a Medicine in WalesJessica R Burton, Kate Halsby, Graciela Sáinz de la Fuente, et al.Pharmacoeconomics|November 4, 2024
Recurrence of Cardiovascular Events After an Acute Myocardial Infarction in Patients with Multivessel Disease and Associated Healthcare Costs: A German Claims Data AnalysisAlexandra Starry, Nils Picker, Jonathan Galduf, et al.Pharmacoeconomics|November 25, 2024
A Multistate Model Incorporating Relative Survival Extrapolation and Mixed Time Scales for Health Technology AssessmentEnoch Yi-Tung Chen, Paul W Dickman, Mark S ClementsPharmacoeconomics|November 21, 2024
Economic Evaluations of Non-Pharmacological Interventions for Treating Disorders of Gut-Brain Interaction: A Scoping ReviewAnton Pak, Madeline O'Grady, Gerald Holtmann, et al.Pageof 336